New Zealand markets closed

Merck & Co., Inc. (MRK)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
73.34-0.55 (-0.74%)
At close: 04:02PM EST
73.36 +0.02 (+0.03%)
After hours: 07:59PM EST
Full screen
Trade prices are not sourced from all markets
Previous close73.89
Bid0.00 x 1800
Ask0.00 x 1200
Day's range72.66 - 74.25
52-week range68.44 - 91.40
Avg. volume16,667,671
Market cap185.252B
Beta (5Y monthly)0.47
PE ratio (TTM)25.88
EPS (TTM)2.83
Earnings date03 Feb 2022
Forward dividend & yield2.76 (3.74%)
Ex-dividend date14 Dec 2021
1y target est94.79
  • Motley Fool

    Here's Why Merck Lost Nearly $40 Billion in Value During November

    Shares of pharma giant Merck (NYSE: MRK) fell by 14.9% during the month of November, according to data from S&P Global Market Intelligence. Although the drugmaker did take a hit from a clinical setback for its once-weekly oral treatment, MK-8507, for HIV-1 infection last month, the main reason Merck's stock slumped in November is the evolving situation surrounding its oral coronavirus pill molnupiravir. In brief, this COVID-19 pill, which is being jointly developed with privately held Ridgeback Biotherapeutics, exhibited a significant drop in efficacy following the final analysis of the full data set, compared to a prior interim data readout.

  • Simply Wall St.

    Merck (NYSE:MRK) Has Announced That It Will Be Increasing Its Dividend To US$0.69

    Merck & Co., Inc. ( NYSE:MRK ) has announced that it will be increasing its dividend on the 7th of January to US$0.69...

  • Yahoo Finance

    Guess who pays for all those millions of COVID-19 vaccines

    Omicron happened this week. So as the medical world shifts to a yet-to-be-determined degree, a question comes to mind: Who will pay for all this? In fact, who’s paid for all the COVID fighting to date?